Literature DB >> 2508171

Comparisons of referral criteria for public screening of blood cholesterol levels.

R G Wones1, K M Kerman, D C Hissa, N Meloy, E A Stein.   

Abstract

Total and high-density lipoprotein (HDL) cholesterol levels of 2,387 adults were screened at a worksite and a bloodbank. Hypothetical referral decisions were made according to three sets of guidelines: the 1984 National Institutes of Health Consensus Conference guidelines (NIHCC), a single referral cutpoint of 5.2 millimoles per liter (mmol per L), and the current National Cholesterol Education Program (NCEP) guidelines for screening in physicians' office. Under the NIHCC guidelines, 31 percent of the participants would have been referred to their physicians, 32 percent under the NCEP guidelines, and 56 percent would have been referred had the 5.2 mmol per L cutpoint been used. Twenty-four percent of the participants would have been referred under both the NIHCC and NCEP guidelines; 7 percent would have been referred under the NIHCC guidelines, but not the NCEP's. Eight percent would have been referred under the NCEP guidelines, but not the NIHCC's. Those who would have been referred were older, and more likely to be male and to have low levels of HDL cholesterol than the 7 percent who would have been referred under NIHCC guidelines only. All of the 8 percent had coronary heart disease, or two or more other coronary risk factors, whereas none of the 7 percent did. If low HDL had been used as a risk factor under NCEP guidelines, the number of persons referred would have increased slightly (to 34 percent) and low HDL levels would have become one of the most prevalent risk factors. The researchers concluded that public cholesterol screening programs should use the NCEP guidelines (with or without HDL), rather than the NIHCC guidelines, or a single 5.2 mmol per L cutpoint.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508171      PMCID: PMC1579962     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  7 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  Feasibility of large-scale cholesterol screening: experience with a portable capillary-blood testing device.

Authors:  P Greenland; J C Levenkron; M G Radley; J G Baggs; R A Manchester; N L Bowley
Journal:  Am J Public Health       Date:  1987-01       Impact factor: 9.308

3.  High-density lipoprotein cholesterol measurements. A help or hindrance in practical clinical medicine?

Authors:  H R Superko; P S Bachorik; P D Wood
Journal:  JAMA       Date:  1986-11-21       Impact factor: 56.272

Review 4.  Reliability of lipid, lipoprotein, and apolipoprotein measurements.

Authors:  H K Naito
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

5.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

Authors:  W P Castelli; R J Garrison; P W Wilson; R D Abbott; S Kalousdian; W B Kannel
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

6.  Population screening for cholesterol determination. A pilot study.

Authors:  E L Wynder; F Field; N J Haley
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

7.  Lipid concentrations in serum and EDTA-treated plasma from fasting and nonfasting normal persons, with particular regard to high-density lipoprotein cholesterol.

Authors:  A R Folsom; K Kuba; R V Leupker; D R Jacobs; I D Frantz
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

  7 in total
  3 in total

1.  The yield of cholesterol screening in an urban black community.

Authors:  N K Russell; D M Becker; C P Finney; H Moses
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

2.  Prevalence of elevated serum cholesterol in personnel of the U.S. Navy.

Authors:  L K Trent
Journal:  Public Health Rep       Date:  1991 Mar-Apr       Impact factor: 2.792

3.  Screening for hypercholesterolemia among Canadians: how much will it cost?

Authors:  S A Grover; L Coupal; R Fahkry; S Suissa
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.